Psoriatic arthritisCOVID-19 has changed the global health system and has great impact on different types of medical specialties including, dermatology and rheumatology. This point is important because although these two specialties are distinct subfields of medicine, there is some overlap between them....
[8]Queiro Silva R, Armesto S, González Vela C, Naharro Fernández C, González-Gay MA. COVID-19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy vs apremilast in North Spain. Dermatol Ther. 20...
This study aimed to conduct a comprehensive systematic literature review and meta-analysis to assess the risk and outcomes of coronavirus disease 2019 (COVID-19) in patients with rheumatoid arthritis. A systematic search was performed across four electro
PSORIATIC arthritisRESPIRATORY infectionsMIDDLE East respiratory syndromeSARS-CoV-2CYTOKINE release syndromeComplicated coronavirus disease 2019 (COVID-19) in a psoriatic patient treated with ixekizumab COVID-19 is caused by the SARS-CoV-2 virus, a new variant beta-coronavirus first isolated from the ...
Saakshi Khattri, MD, discussing navigating the first days of the COVID-19 pandemic with her psoriatic arthritis patients.
in the view of COVID-19 was rheumatoid arthritis (RA) (n = 527), followed by systemic lupus erythematosus (SLE) (n = 393), vasculitis (n = 267), myositis (n = 71), systemic sclerosis (SSc) (n = 68), and psoriatic arthritis (PsA) (n = 68), Fig....
PSORIATIC arthritisDear Editor, Italian authors published recently in the journal of Dermatologic Therapy their recommendations for treatment of patients with psoriasis at time of new COVID-19 pandemic. The authors pointed to the importance of therapeutic reassessment of all psoriatic patients, ...
Baricitinib is a small molecule compound that selectively inhibits the kinase activity of JAK1 and JAK2. Baricitinib can be used in combination with one or more TNF inhibitors and is approved for the treatment of rheumatoid arthritis48 and psoriatic arthritis.49 Through searching the BenevolentAI data...
Therefore, it is no surprise that patients with rheumatic diseases (e.g. rheumatoid arthritis and psoriatic arthritis), and related immune-mediated inflammatory conditions (e.g. IBD) which utilise higher doses of agents targeting this pathway do not appear to have an increased risk of COVID-19...
The most common inflammatory RMDs were rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis. The most common non-inflammatory RMDs were osteoarthritis and osteoporosis. Among people with inflammatory RMDs, 54% were taking a conventional synthetic disease-modifying antirheumatic drug (csDMARD...